Dignitana to address Stockholm Corporate Finance Life Science Seminar

Dignitana AB, global leader in scalp cooling innovation, will participate in the fourteenth annual Stockholm Corporate Finance Life Science Capital Markets Days on 9 March 2022. Beginning at 1130 CET Dignitana CEO William Cronin will deliver a 30-minute presentation of the company’s strategic growth and discuss current reimbursement initiatives.

Files for download
Dignitana Release - wkr0006.pdf

The seminar will be a live digital broadcast. To register as a participant for the Capital Markets Day, use this link: https://www.lyyti.in/SCF-Life-Science-Kapmarknadsdagar-2022

Stockholm Corporate Finance, in conjunction with Financial Hearings and Nyhetsbyrån Direkt, has organized the event to give investors, analysts and financial media the opportunity to meet companies in the Life Science and Health Care industry.

For More Information Contact 

Melissa Bourestom, VP Corporate Communications,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.com or www.dignicap.com